Micromet Reports CancerVax Corporation’s First Quarter 2006 Financial Results

Merger of Micromet AG and CancerVax Corporation Has Created Biopharmaceutical Company with Highly Differentiated Pipeline of Antibody-Based Drug Candidates

MORE ON THIS TOPIC